Lunit Inc. Share Price

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
36,100.00 ^KRW	0.00%		-11.30%	-12.17%

03-04	Lunit Inc. Announces Early Breast Cancer Risk Assessment Study at ECR 2026	CI
03-04	Harrison.ai Continues to Grow Open Platform Ecosystem, Welcomes Four New AI Partners	CI

Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

04-22 - Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
06/03/26	36,100.00 ₩	0.00%	158,830
05/03/26	36,100.00 ₩	+8.73%	340,770
04/03/26	33,200.00 ₩	-14.21%	535,170
03/03/26	38,700.00 ₩	-4.91%	310,274
27/02/26	40,700.00 ₩	0.00%	190,481

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

36,100.00KRW

Average target price

30,000.00KRW

Spread / Average Target

-16.90%

Consensus

Annual profits - Rate of surprise

Company calendar

Stock Market
Equities
A328130 Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Capitalization	1,057B 712M 614M 554M 532M 969M 65.42B 1.01B 6.55B 2.62B 31.37B 2.67B 2.61B 112B	P/E ratio 2025 *	-	P/E ratio 2026 *	-
Enterprise value	1.07B 721K 622K 561K 538K 982K 66.25M 1.03M 6.63M 2.66M 31.77M 2.71M 2.65M 114M	EV / Sales 2025	14.5x	EV / Sales 2026 *	10.2x
Free-Float	75.63%	Yield 2025 *	-	Yield 2026 *	-

03-04	Lunit Inc. Announces Early Breast Cancer Risk Assessment Study at ECR 2026	CI
03-04	Harrison.ai Continues to Grow Open Platform Ecosystem, Welcomes Four New AI Partners	CI
02-23	Lunit Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-30	Lunit Inc to conduct capital increase of 250 billion won	RE
01-06	Lunit Inc. announced that it has received KRW 800 billion in funding from Atinum Investment Co., Ltd	CI
12-15	Lunit announces collaboration with Daiichi Sankyo on AI-driven biomarker discovery	RE
12-15	Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research	CI
12-08	Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model	CI
12-02	Lunit Inc. to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025	CI
12-01	SimonMed Imaging to Transform Chest X-Ray Report Generation with Lunit's Multimodal Foundation Models	CI
11-17	Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research	CI
11-13	Lunit Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/10/25	Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer At ESMO 2025	CI

26/11/24	Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts	AQ
11/11/24	Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024	AQ
24/10/24	Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance	AQ
23/07/24	Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program	AQ
27/03/24	Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients	AQ

1 week	-11.30%
Current month	-11.30%
1 month	-10.31%
3 months	-8.03%
6 months	-16.34%
Current year	-12.17%

1 week	32,750	41,500
1 month	32,750	44,250
Current year	32,750	49,800
1 year	32,750	60,700
3 years	18,300	139,750
5 years	9,450	139,750
10 years	9,450	139,750

Lunit Inc. Share Price

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

Valuation: Lunit Inc.

Chart: Lunit Inc.

Latest news: Lunit Inc.

Press Releases: Lunit Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Lunit Inc.

Medical Software & Technology Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

Manager	Title	Age	Since
Jung-Min Lee CTO	Chief Tech/Sci/R&D Officer	41	22/08/2013
Beom-Seok Suh CEO	Chief Executive Officer	43	31/12/2015
Sung-Gyun Park PRN	Corporate Officer/Principal	40	-

Director	Title	Age	Since
Seung-Uk Paek CHM	Chairman	43	-
Beom-Seok Suh BRD	Director/Board Member	43	31/12/2015
Garheng Albert Kong BRD	Director/Board Member	50	29/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
LUNIT INC.	0.00%	-11.30%	-29.77%	+52.32%	712M
VEEVA SYSTEMS INC.	-0.29%	+7.41%	-20.79%	+11.66%	32.14B
PRO MEDICUS LIMITED	+9.23%	+2.08%	-47.76%	+114.86%	9.73B
SECTRA AB	+13.98%	+9.39%	-7.93%	+44.71%	4.44B
QINGSONG HEALTH CORPORATION	-8.11%	-4.73%	-	-	2.29B
HEARTFLOW, INC.	-7.56%	-0.78%	-	-	1.96B
OMNICELL, INC.	-2.25%	+0.49%	+11.65%	-23.09%	1.88B
GENERATE BIOMEDICINES, INC.	-9.96%	-11.38%	-	-	1.43B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+4.34%	-2.94%	-46.42%	-	1.23B
B-SOFT CO.,LTD.	+1.60%	-6.10%	-24.07%	-44.11%	1.14B
Average	+0.10%	-1.29%	-23.58%	+26.06%	5.69B
Weighted average by Cap.	+1.72%	+4.46%	-24.42%	+32.67%

	2025	2026 *
Net sales	78.81B 53.06M 45.75M 41.3M 39.63M 72.26M 4.88B 75.63M 488M 196M 2.34B 199M 195M 8.36B	95.12B 64.05M 55.22M 49.85M 47.83M 87.22M 5.89B 91.29M 589M 236M 2.82B 240M 235M 10.1B
Net income	-35.17B -23.68M -20.42M -18.43M -17.68M -32.25M -2.18B -33.75M -218M -87.29M -1.04B -88.87M -86.98M -3.73B	-123B -82.94M -71.51M -64.56M -61.94M -113M -7.62B -118M -763M -306M -3.66B -311M -305M -13.07B
Net Debt	13.37B 9M 7.76M 7.01M 6.72M 12.26M 827M 12.83M 82.82M 33.18M 397M 33.78M 33.06M 1.42B	-88.12B -59.34M -51.16M -46.18M -44.31M -80.81M -5.45B -84.57M -546M -219M -2.62B -223M -218M -9.35B